VO-OHPic

VO-OHPic

Cat. No.: DIA-0243049

Size: 50 mg Size: 100 mg Size: 250 mg Size: Customer Size
Product Information
CAS No. 675848-25-6
Formula C12H10N2O8V
Molecular Weight 361.16
SMILES [OH2][V+2]([N]1=CC=CC(O)=C1C2=O)([O-]2)([O-]C3=CC=CN=C3C4=O)([O-]4)=O.[H+]
Target PTEN, Apoptosis, Autophagy
Product Description VO-OHPic is a reversible, noncompetitive and selective PTEN inhibitor with an IC50 of 46 nM. VO-OHPic attenuates apoptosis, adverse cardiac remodeling, and pro-inflammatory M1 macrophages in doxorubicin-induced cardiomyopathy. VO-OHPic inhibits autophagy.
Format & Storage
Shipping Room temperature in the continental U.S. Other areas may vary.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
logo

Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top